WellPoint says e-prescribing could be a Trojan horse for HIE

E-prescribing very well could be the tool that knocks down significant barriers to health information exchange, particularly on the payer side of the equation, according to a WellPoint executive.

Speaking at the AHIP Institute in San Francisco, WellPoint VP of Health Information Technology Charles Kennedy, M.D., said that e-prescribing can pay immediate dividends in terms of cost and outcomes, helping to overcome the lack of coordination of care with current EHRs and the perception that clinically focused RHIOs are failing. But it is up to insurers to provide physicians with data showing the value of the technology, he said.

 For details:
- check out the Health Data Management story

- DEA prepares proposal to allow e-prescribing of controlled substances. Summary

Suggested Articles

Consumer groups are urging regulators to scrutinize Google's $2.1 billion bid for Fitbit, citing privacy and competition concerns.

Health benefits platform Accolade made its debut on the public market Thursday, raising $220 million at a valuation of $1.2 billion.

Here are the healthcare startups trying to shake up the $260 billion primary care market.